452 Participants Needed

Online Pain Coping Skills Training for Joint Pain in Breast Cancer Survivors

Recruiting at 1 trial location
CR
RO
ZH
Overseen ByZahra Hosseinian
Age: 18+
Sex: Female
Trial Phase: Phase 3
Sponsor: Northwestern University
Must be taking: AI therapy
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

What is the purpose of this trial?

The main goal of this clinical trial is to test benefits of completing online pain coping skills training program in women who have been diagnosed with stage I-III breast cancer, who have completed their primary cancer treatment, who are taking an AI medication, and who have arthralgia. Arthralgia is a type of joint, bone, and muscle pain that is a common side effect of AI medications. The main questions it aims to answer are: 1. Whether online pain coping skills training reduces the severity of pain and the interference it causes in women's daily lives. 2. Whether online pain coping skills training improves emotional distress, quality of life, and adherence to AI medications. 3. Whether benefits of online pain coping skills training are at least partially caused by women's increased confidence that they can manage their pain and a reduction in unhelpful thinking patterns about pain. 4. Whether online pain coping skills training improves effects of AI medications on sleep problems and symptoms of menopause like hot flashes and night sweats. Participants can complete all parts of the study at home. They will: 1. Complete four sets of questionnaires throughout the study, which will take about 9 to 10 months. 2. Attend 3 meetings in the first month of the study, all of which can be held via a video conference. 3. Use an electronic pill bottle to track their use of their AI medication. 4. Be randomized (like flipping a coin) to one of two study arms: They will either receive education about AIs and arthralgia or they will receive this education along with access to an online pain coping skills training program. Research will compare the education group to the education plus online pain coping skills training group to see if online pain coping skills training has the benefits mentioned above.

Will I have to stop taking my current medications?

The trial does not require you to stop taking your current medications. However, if you are taking pain relievers, you need to be on a stable dose for at least 14 days before joining the study and should not plan to increase the dose during the study. You can discuss any changes with your doctor.

What data supports the effectiveness of this treatment for joint pain in breast cancer survivors?

Research shows that educational interventions for cancer pain can help reduce pain intensity and improve understanding of pain. These programs, which include teaching about pain and self-management strategies, have been found to be beneficial for cancer patients experiencing pain.12345

Is online pain coping skills training safe for humans?

The studies suggest that online pain coping skills training is generally safe for humans, as they focus on its acceptability and satisfaction among participants, without reporting any significant safety concerns.12467

How is the Online Pain Coping Skills Training treatment different from other treatments for joint pain in breast cancer survivors?

This treatment is unique because it is delivered online, making it more accessible to patients who may face barriers like travel or physical burden. It focuses on teaching pain coping skills, which is a behavioral approach, rather than relying on medication or in-person therapy sessions.16789

Eligibility Criteria

This trial is for postmenopausal women over 18 with Stage I-III hormone receptor positive breast cancer, who've finished primary treatment and are on stable AI therapy experiencing joint pain. They must be English-speaking, able to use digital devices for online training, and likely to complete the study.

Inclusion Criteria

I am currently on AI therapy (letrozole, exemestane, or anastrozole).
My joint or muscle pain started or got worse after beginning AI therapy.
My pain medication dose has been stable for the last 2 weeks and I don't plan to increase it during the study.
See 11 more

Exclusion Criteria

Have diagnosed or suspected condition that would interfere with informed consent or completion of study activities (e.g., significant impairment in cognition or uncorrected hearing/vision)
I am postmenopausal because of medical treatment, not natural causes.
I had major surgery less than 8 weeks ago or minor surgery recently, as approved.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive education about AIs and arthralgia, with or without access to an online pain coping skills training program, completed over 8 to 10 weeks.

8-10 weeks
3 meetings (virtual) in the first month

Follow-up 1

Participants' medication adherence is monitored using electronic pill bottles.

10-14 weeks

Follow-up 2

Participants are monitored for changes in menopause-specific quality of life.

22-26 weeks

Follow-up 3

Participants are monitored for changes in pain, emotional distress, sleep disturbance, and medication adherence.

34-38 weeks

Treatment Details

Interventions

  • Education
  • Online Pain Coping Skills Training
Trial OverviewThe trial tests if an online pain coping skills program can reduce pain severity from AI medication in breast cancer survivors, improve their quality of life, emotional distress, sleep issues, menopause symptoms and adherence to AI medications.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Education + Online Pain Coping Skill TrainingExperimental Treatment2 Interventions
Participants will receive their usual medical care and an educational booklet with information about Aromatase Inhibitors (AIs), side effects they cause including painful arthralgia, methods for managing arthralgia, and tips for talking with doctors about arthralgia and other AI side effects. They will also be given access to an online pain coping skills training program and asked to complete it at home over 8 to 10 weeks. This interactive, web-based program teaches cognitive and behavioral skills that research has shown can reduce pain and pain-related interference with daily activities. The program includes eight sessions that participants will complete at a rate of about 1 per week. Each session takes 35-45 minutes. Participants will be shown how to use the program and can contact the study team if they have any problems with it. Participants who do not have a device capable of accessing the program will be loaned a tablet computer for the study.
Group II: EducationActive Control1 Intervention
Participants will receive their usual medical care and an educational booklet with information about Aromatase Inhibitors (AIs), side effects they cause including painful arthralgia, methods for managing arthralgia, and tips for talking with doctors about arthralgia and other AI side effects.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northwestern University

Lead Sponsor

Trials
1,674
Recruited
989,000+

Duke University

Collaborator

Trials
2,495
Recruited
5,912,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Findings from Research

The personalized eHealth intervention for female breast cancer survivors with persistent pain was well-received, being described as easy to use and helpful, indicating strong acceptability and satisfaction among participants.
After 6 weeks of using the program, participants showed significant improvements in pain-related functioning, physical functioning, and quality of life, suggesting the intervention's preliminary efficacy in managing post-surgery pain.
Feasibility and pilot testing of a personalized eHealth intervention for pain science education and self-management for breast cancer survivors with persistent pain: a mixed-method study.De Groef, A., Evenepoel, M., Van Dijck, S., et al.[2023]
Educational interventions for healthcare professionals improve their knowledge and attitudes towards cancer pain management, but this does not always lead to better patient outcomes.
Targeted educational programs for patients have been shown to improve their outcomes, suggesting that patient education is crucial, although the exact mechanisms of these improvements are still unclear.
Education in cancer pain management.Bennett, MI., Flemming, K., Closs, SJ.[2021]
Educational interventions for cancer pain management can lead to small to moderate reductions in pain intensity for patients, based on a review of 34 randomized controlled trials.
These interventions often include key components such as improving knowledge about cancer pain, enhancing communication, and teaching non-pharmacological pain management strategies, indicating a multifaceted approach is effective.
Educational interventions for cancer pain. A systematic review of systematic reviews with nested narrative review of randomized controlled trials.Adam, R., Bond, C., Murchie, P.[2022]

References

Feasibility and pilot testing of a personalized eHealth intervention for pain science education and self-management for breast cancer survivors with persistent pain: a mixed-method study. [2023]
Education in cancer pain management. [2021]
Educational interventions for cancer pain. A systematic review of systematic reviews with nested narrative review of randomized controlled trials. [2022]
Developing effective cancer pain education programs. [2022]
Effectiveness of Therapeutic Education in Patients with Cancer Pain: Systematic Review and Meta-Analysis. [2023]
A qualitative study of patient and provider perspectives on using web-based pain coping skills training to treat persistent cancer pain. [2020]
A Pilot Study of a Mobile Health Pain Coping Skills Training Protocol for Patients With Persistent Cancer Pain. [2018]
A behavioral cancer pain intervention: A randomized noninferiority trial comparing in-person with videoconference delivery. [2023]
Meaning-Centered Pain Coping Skills Training: A Pilot Feasibility Trial of a Psychosocial Pain Management Intervention for Patients with Advanced Cancer. [2023]